Research Article
Year 2021,
, 276 - 284, 30.06.2021
Abstract
References
- [1] Crofford L.J., Use of NSAIDs in Treating Patients with Arthritis, Arthritis Res. Ther., 15 (S3) (2013) S2.
- [2] Simon L.S., Nonsteroidal Anti-inflammatory Drugs and Their Risk: A Story Still in Development, Arthritis Res. Ther., 15 (S3) (2013) S1.
- [3] Cha Y.I., DuBois R.N., NSAIDs and Cancer Prevention: Targets Downstream of COX-2, Annu. Rev. Med., 58 (2007) 239-252.
- [4] Tinsley H.N., Grizzle W.E., Abadi A., Keeton A., Zhu B., Xi Y., Piazza G.A., New NSAID Targets and Derivatives for Colorectal Cancer Chemoprevention, Recent Results Cancer Res., 191 (2013), 105-120.
- [5] Wang D., DuBois R.N., The Role of Anti-inflammatory Drugs in Colorectal Cancer, Annu. Rev. of Med., 64 (2013) 131-144.
- [6] Gurpinar E., Grizzle W.E., Piazza G.A., NSAIDs Inhibit Tumorigenesis, But How?, Clin. Cancer Res., 20(5) (2014) 1104-1113.
- [7] Tsioulias G.J., Go M.F., Rigas B., NSAIDs and Colorectal Cancer Control: Promise and Challenges, Curr. Pharmacol. Rep., 1(5) (2015) 295-301.
- [8] Stambaugh Jr J.E., Drew J., The Combination of Ibuprofen and Oxycodone/Acetaminophen in the Management of Chronic Cancer Pain, Clin. Pharmacol. Ther., 44(6) (1988) 665-669.
- [9] Portenoy, R.K., Lesage P., Management of cancer pain, Lancet, 353(9165) (1999) 1695-1700.
- [10] Derry S., Wiffen P.J., Moore R., McNicol E.D., Bell R.F., Carr D.B., McIntyre M., Wee B., Oral Nonsteroidal Anti-Inflammatory Drugs (Nsaids) for Cancer Pain in Adults, Cochrane Database of Syst. Rev., 7 (2017)
- [11] Carr D.B., Goudas L.C., Balk E.M., Bloch R., Ioannidis J.P., Lau J., Evidence Report on the Treatment of Pain in Cancer Patients, J. Natl. Cancer Inst. Monogr., 32 (2004) 23-31.
- [12] Abdulla A., Adams N., Bone M., Elliott A.M., Gaffin J., Jones D., Knaggs R., Martin D., Sampson L., Schofield P., British Geriatric Society, Guidance on the Management of Pain in Older People, Age Ageing, 42 (S1) (2013) 1-57.
- [13] Kamsvåg, T., Hedén L., Essen L. V. Ljungman G., Ibuprofen in Needle Procedures in Children with Cancer—A Feasibility and Pilot study, Acta Paediatr., 110 (2) (2020) 704-710.
- [14] Rainsford, K., Ibuprofen: Pharmacology, Efficacy and Safety, Inflammopharmacology, 17(6) (2009) 275-342.
- [15] Leising G., Resel R., Stelzer F., Tasch S., Lanziner A., Hantich G., Physical Aspects of Dexibuprofen and Racemic Ibuprofen, J. Clin. Pharmacol., 36(12) (1996) 3S-6S.
- [16] Davies N.M., Clinical Pharmacokinetics of Ibuprofen, Clin. Pharmacokinet, 34(2) (1998) 101-154.
- [17] Locatelli M., Tartaglia A., D'Ambrosio F., Ramundo P., Ulusoy H.I., Furton K.G., Kabir A., Biofluid Sampler: A New Gateway for Mail-in-Analysis of Whole Blood Samples, J. Chromatogr. B., 1143 (2020) 122055.
- [18] D'Angelo V., Tessari F., Bellagamba G., De Luca E., Cifelli R., Celia C., Primavera R., Di Francesco M., Paolino D., Di Marzio L., Locatelli M., Microextraction by Packed Sorbent and HPLC–PDA Quantification of Multiple Anti-Inflammatory Drugs and Fluoroquinolones in Human Plasma and Urine, J. Enzyme Inhib. Med. Chem., 31(Sup3) (2016) 110-116.
- [19] Çelebier M., Nenni M., Altınöz S., Ultrafiltration-Based Extraction and HPLC Analysis of Naproxen Sodium in Human Plasma Samples: An Innovative Approach to Pharmaceutical Analysis, Pharm. Chem. J., 50(4) (2016) 275-279.
- [20] FDA, Guidance for Industry: Bioanalytical Method Validation. 2018.
- [21] Tartaglia A., Kabir A., D'Ambrosio F., Ramundo P., Ulusoy S., Ulusoy H.I., Merone G.M., Savini F., D'Ovidio C., Grazia U., Furton K.G., Locatelli M., Fast Off-line FPSE-HPLC-PDA Determination of Six NSAIDs in Saliva Samples, J. Chromatogr. B., 1144 (2020) 122082.
- [22] Locatelli M., Tartaglia A., Ulusoy H. I., Ulusoy S., Savini F., Rossi S., Santavenere F., Merone G. M., Bassotti E., D’Ovidio C., Rosato E., Furton K. G., Kabir A., Fabric-Phase Sorptive Membrane Array As a Noninvasive In Vivo Sampling Device For Human Exposure To Different Compounds, Anal. Chem., 93(4) (2021) 1957-1961.
- [23] Karaca E., Ulusoy S, Morgül Ü., Ulusoy H., Development of Analytical Method for Sensitive Determination of Streptozotocin Based on Solid Phase Extraction, Cumhuriyet Sci. J., 41(4) (2020) 826-831.
- [24] Bonfilio R., Cazedey E. C. L., de Araújo M. B., Salgado H. R. N., Analytical Validation of Quantitative High-Performance Liquid Chromatographic Methods in Pharmaceutical Analysis: A Practical Approach, Crit. Rev. Anal. Chem., 42 (1) (2012) 87-100.
Ultrafiltration-Based extraction of Ibuprofen from human plasma samples and HPLC analysis: developing an innovative bioanalytical analysis method
Abstract
Some commercially available scientific products for ultrafiltration are readily available and have been used for a long time, especially in environmental sciences, life sciences and analysis of active ingredients from plants. Recent studies of metabolomics discuss the advantage and disadvantage of ultrafiltration versus protein precipitation and solid phase extraction. However, ultrafiltration techniques are rarely used in pharmaceutical analysis, even though they have advantages over solid phase extraction, such as easy to apply and no buffer preparations. The aim of this study is to develop a simple and innovative analysis technique for IBU determination from human plasma samples by ultrafiltration-based extraction in a pharmaceutical analysis. the prepared samples were analyzed using HPLC system equipped with C18 Column (100 x 4.6 mm, 3.5 µm). The flow rate was set to 1.0 mL min-1 while using isocratic elution with the mobile phase of [acetonitrile: phosphate buffer (pH 3.0, 15 mM) (56:44 v/v)] solution. Injection volume was 20 μL and UV detection was performed at 220 nm wavelenght. The developed method was validated according to FDA Bioanalytical Guidelines and found accurate, precise, sensitive, selective and efficient with the high recovery values samples.
References
- [1] Crofford L.J., Use of NSAIDs in Treating Patients with Arthritis, Arthritis Res. Ther., 15 (S3) (2013) S2.
- [2] Simon L.S., Nonsteroidal Anti-inflammatory Drugs and Their Risk: A Story Still in Development, Arthritis Res. Ther., 15 (S3) (2013) S1.
- [3] Cha Y.I., DuBois R.N., NSAIDs and Cancer Prevention: Targets Downstream of COX-2, Annu. Rev. Med., 58 (2007) 239-252.
- [4] Tinsley H.N., Grizzle W.E., Abadi A., Keeton A., Zhu B., Xi Y., Piazza G.A., New NSAID Targets and Derivatives for Colorectal Cancer Chemoprevention, Recent Results Cancer Res., 191 (2013), 105-120.
- [5] Wang D., DuBois R.N., The Role of Anti-inflammatory Drugs in Colorectal Cancer, Annu. Rev. of Med., 64 (2013) 131-144.
- [6] Gurpinar E., Grizzle W.E., Piazza G.A., NSAIDs Inhibit Tumorigenesis, But How?, Clin. Cancer Res., 20(5) (2014) 1104-1113.
- [7] Tsioulias G.J., Go M.F., Rigas B., NSAIDs and Colorectal Cancer Control: Promise and Challenges, Curr. Pharmacol. Rep., 1(5) (2015) 295-301.
- [8] Stambaugh Jr J.E., Drew J., The Combination of Ibuprofen and Oxycodone/Acetaminophen in the Management of Chronic Cancer Pain, Clin. Pharmacol. Ther., 44(6) (1988) 665-669.
- [9] Portenoy, R.K., Lesage P., Management of cancer pain, Lancet, 353(9165) (1999) 1695-1700.
- [10] Derry S., Wiffen P.J., Moore R., McNicol E.D., Bell R.F., Carr D.B., McIntyre M., Wee B., Oral Nonsteroidal Anti-Inflammatory Drugs (Nsaids) for Cancer Pain in Adults, Cochrane Database of Syst. Rev., 7 (2017)
- [11] Carr D.B., Goudas L.C., Balk E.M., Bloch R., Ioannidis J.P., Lau J., Evidence Report on the Treatment of Pain in Cancer Patients, J. Natl. Cancer Inst. Monogr., 32 (2004) 23-31.
- [12] Abdulla A., Adams N., Bone M., Elliott A.M., Gaffin J., Jones D., Knaggs R., Martin D., Sampson L., Schofield P., British Geriatric Society, Guidance on the Management of Pain in Older People, Age Ageing, 42 (S1) (2013) 1-57.
- [13] Kamsvåg, T., Hedén L., Essen L. V. Ljungman G., Ibuprofen in Needle Procedures in Children with Cancer—A Feasibility and Pilot study, Acta Paediatr., 110 (2) (2020) 704-710.
- [14] Rainsford, K., Ibuprofen: Pharmacology, Efficacy and Safety, Inflammopharmacology, 17(6) (2009) 275-342.
- [15] Leising G., Resel R., Stelzer F., Tasch S., Lanziner A., Hantich G., Physical Aspects of Dexibuprofen and Racemic Ibuprofen, J. Clin. Pharmacol., 36(12) (1996) 3S-6S.
- [16] Davies N.M., Clinical Pharmacokinetics of Ibuprofen, Clin. Pharmacokinet, 34(2) (1998) 101-154.
- [17] Locatelli M., Tartaglia A., D'Ambrosio F., Ramundo P., Ulusoy H.I., Furton K.G., Kabir A., Biofluid Sampler: A New Gateway for Mail-in-Analysis of Whole Blood Samples, J. Chromatogr. B., 1143 (2020) 122055.
- [18] D'Angelo V., Tessari F., Bellagamba G., De Luca E., Cifelli R., Celia C., Primavera R., Di Francesco M., Paolino D., Di Marzio L., Locatelli M., Microextraction by Packed Sorbent and HPLC–PDA Quantification of Multiple Anti-Inflammatory Drugs and Fluoroquinolones in Human Plasma and Urine, J. Enzyme Inhib. Med. Chem., 31(Sup3) (2016) 110-116.
- [19] Çelebier M., Nenni M., Altınöz S., Ultrafiltration-Based Extraction and HPLC Analysis of Naproxen Sodium in Human Plasma Samples: An Innovative Approach to Pharmaceutical Analysis, Pharm. Chem. J., 50(4) (2016) 275-279.
- [20] FDA, Guidance for Industry: Bioanalytical Method Validation. 2018.
- [21] Tartaglia A., Kabir A., D'Ambrosio F., Ramundo P., Ulusoy S., Ulusoy H.I., Merone G.M., Savini F., D'Ovidio C., Grazia U., Furton K.G., Locatelli M., Fast Off-line FPSE-HPLC-PDA Determination of Six NSAIDs in Saliva Samples, J. Chromatogr. B., 1144 (2020) 122082.
- [22] Locatelli M., Tartaglia A., Ulusoy H. I., Ulusoy S., Savini F., Rossi S., Santavenere F., Merone G. M., Bassotti E., D’Ovidio C., Rosato E., Furton K. G., Kabir A., Fabric-Phase Sorptive Membrane Array As a Noninvasive In Vivo Sampling Device For Human Exposure To Different Compounds, Anal. Chem., 93(4) (2021) 1957-1961.
- [23] Karaca E., Ulusoy S, Morgül Ü., Ulusoy H., Development of Analytical Method for Sensitive Determination of Streptozotocin Based on Solid Phase Extraction, Cumhuriyet Sci. J., 41(4) (2020) 826-831.
- [24] Bonfilio R., Cazedey E. C. L., de Araújo M. B., Salgado H. R. N., Analytical Validation of Quantitative High-Performance Liquid Chromatographic Methods in Pharmaceutical Analysis: A Practical Approach, Crit. Rev. Anal. Chem., 42 (1) (2012) 87-100.
There are 24 citations in total.
Details
| Primary Language | English |
|---|---|
| Subjects | Pharmacology and Pharmaceutical Sciences |
| Journal Section | Natural Sciences |
| Authors | |
| Publication Date | June 30, 2021 |
| Submission Date | December 12, 2020 |
| Acceptance Date | April 17, 2021 |
| Published in Issue | Year 2021 |